Germany has a high demand in meniscal allograft transplantation but is subject to health economic and legal challenges: a survey of the German Knee Society - Takeaways - MDSpire

Germany has a high demand in meniscal allograft transplantation but is subject to health economic and legal challenges: a survey of the German Knee Society

  • By

  • Philipp W. Winkler

  • Svea Faber

  • Maurice Balke

  • Sebastian Metzlaff

  • Thomas R. Niethammer

  • Philip P. Roessler

  • Ralf Henkelmann

  • Alexander Kurme

  • Sebastian Colcuc

  • Gerald Zimmermann

  • Wolf Petersen

  • Theresa A. Diermeier

  • January 31, 2022

  • 0 min

Share

  • 1

    Meniscal allograft transplantation (MAT) is a viable treatment for symptomatic meniscus deficiency, improving quality of life and athletic performance.

  • 2

    Germany faces significant challenges in MAT, including reimbursement issues, legal jurisdiction, and limited availability of meniscal allografts.

  • 3

    A survey of the German Knee Society revealed that 91.5% of participants believe MAT is clinically necessary in Germany.

  • 4

    Only 35.5% of survey participants have performed MAT, with most having conducted fewer than 10 procedures in their careers.

  • 5

    The main determinants for considering MAT include patient age, post-meniscectomy syndrome, and the patient's functional and athletic demands.

Original Source(s)

Related Content